| Primary |
| Product Used For Unknown Indication |
58.9% |
| Atrial Fibrillation |
15.3% |
| Arrhythmia |
4.0% |
| Palpitations |
3.2% |
| Afib |
1.6% |
| Anticoagulant Therapy |
1.6% |
| Breast Cancer |
1.6% |
| Intentional Overdose |
1.6% |
| Overdose |
1.6% |
| Supraventricular Extrasystoles |
1.6% |
| Tachyarrhythmia |
1.6% |
| Atrial Flutter |
0.8% |
| Benign Prostatic Hyperplasia |
0.8% |
| Blood Cholesterol |
0.8% |
| Cardioversion |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Depression |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Embolism Venous |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
|
| Toxicity To Various Agents |
47.8% |
| Ventricular Tachycardia |
5.8% |
| Drug Level Increased |
4.3% |
| Inappropriate Antidiuretic Hormone Secretion |
4.3% |
| Type Iii Immune Complex Mediated Reaction |
4.3% |
| Vomiting |
4.3% |
| Atrial Fibrillation |
2.9% |
| Brugada Syndrome |
2.9% |
| Drug Ineffective |
2.9% |
| Drug Interaction |
2.9% |
| Ventricular Arrhythmia |
2.9% |
| Vision Blurred |
2.9% |
| Cardiac Arrest |
1.4% |
| Cardiac Failure Congestive |
1.4% |
| Cholestatic Liver Injury |
1.4% |
| Completed Suicide |
1.4% |
| Electrocardiogram T Wave Inversion |
1.4% |
| Feeling Cold |
1.4% |
| Gastric Ulcer Haemorrhage |
1.4% |
| Gastrointestinal Haemorrhage |
1.4% |
|
| Secondary |
| Product Used For Unknown Indication |
53.8% |
| Atrial Fibrillation |
9.1% |
| Hypertension |
5.3% |
| Thrombosis Prophylaxis |
5.3% |
| Drug Use For Unknown Indication |
4.5% |
| Suicide Attempt |
3.8% |
| Depression |
3.0% |
| Rheumatoid Arthritis |
2.3% |
| Schizoaffective Disorder |
2.3% |
| Arrhythmia |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Prophylaxis |
1.5% |
| Allergy Prophylaxis |
0.8% |
| Arrhythmia Prophylaxis |
0.8% |
| Cardiac Disorder |
0.8% |
| Cervicobrachial Syndrome |
0.8% |
| Chronic Myeloid Leukaemia |
0.8% |
| Diuretic Therapy |
0.8% |
| Emphysema |
0.8% |
| Epilepsy |
0.8% |
|
| Completed Suicide |
12.5% |
| Toxicity To Various Agents |
12.5% |
| Type Iii Immune Complex Mediated Reaction |
12.5% |
| Cholestatic Liver Injury |
6.3% |
| Hypoxia |
6.3% |
| Intentional Overdose |
6.3% |
| Atrial Fibrillation |
3.1% |
| Cardio-respiratory Arrest |
3.1% |
| Coronary Artery Occlusion |
3.1% |
| Drug Level Increased |
3.1% |
| Dysgeusia |
3.1% |
| Fatigue |
3.1% |
| Loss Of Consciousness |
3.1% |
| Micturition Disorder |
3.1% |
| Orthopnoea |
3.1% |
| Overdose |
3.1% |
| Poisoning |
3.1% |
| Rash |
3.1% |
| Rectal Haemorrhage |
3.1% |
| Renal Failure Chronic |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.9% |
| Atrial Fibrillation |
19.9% |
| Hypertension |
12.7% |
| Arrhythmia |
4.4% |
| Cardiac Disorder |
4.2% |
| Diabetes Mellitus |
4.2% |
| Blood Cholesterol Increased |
3.0% |
| Cerebrovascular Accident Prophylaxis |
3.0% |
| Hypothyroidism |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Anticoagulant Therapy |
2.5% |
| Depression |
2.5% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Premedication |
2.5% |
| Drug Use For Unknown Indication |
2.3% |
| Migraine |
2.3% |
| Anxiety |
2.1% |
| Pain |
2.1% |
| Supplementation Therapy |
2.1% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
|
| Wrong Technique In Drug Usage Process |
9.5% |
| Atrial Fibrillation |
8.1% |
| Syncope |
6.8% |
| International Normalised Ratio Increased |
5.4% |
| Rash |
5.4% |
| Tachycardia |
5.4% |
| Ventricular Fibrillation |
5.4% |
| Vomiting |
5.4% |
| Blood Glucose Increased |
4.1% |
| Electrocardiogram Pr Prolongation |
4.1% |
| Myalgia |
4.1% |
| Nausea |
4.1% |
| Oedema Peripheral |
4.1% |
| Pain In Extremity |
4.1% |
| Palpitations |
4.1% |
| Renal Failure Acute |
4.1% |
| Sepsis |
4.1% |
| Spinal Osteoarthritis |
4.1% |
| Surgery |
4.1% |
| Thrombocytopenia |
4.1% |
|
| Interacting |
| Product Used For Unknown Indication |
48.5% |
| Atrial Fibrillation |
21.2% |
| Percutaneous Coronary Intervention |
9.1% |
| Blood Cholesterol Increased |
6.1% |
| Nasopharyngitis |
6.1% |
| Arrhythmia Prophylaxis |
3.0% |
| Gastritis |
3.0% |
| Hypertension |
3.0% |
|
| Liver Function Test Abnormal |
28.6% |
| Toxicity To Various Agents |
28.6% |
| Cardiac Arrest |
14.3% |
| Gastrointestinal Haemorrhage |
14.3% |
| Pain |
14.3% |
|
